Literature DB >> 2354827

Case-control study of in situ and invasive carcinoma of the vagina.

L A Brinton1, P C Nasca, K Mallin, C Schairer, J Rosenthal, R Rothenberg, E Yordan, R M Richart.   

Abstract

A case-control study of 41 patients with carcinoma in situ (CIS) or invasive cancer of the vagina and 97 community controls was undertaken to identify potential risk factors. Although vaginal and cervical cancers often occur as multiple primaries, only a few common risk factors prevailed. Similar to cervical cancer, low education and family income were risk factors for vaginal CIS and invasive cancer. In addition, history of genital warts was strongly related (RR = 2.9), although other sexual factors were not. Previous genital abnormalities related to subsequent cancer risk, with significant associations seen for vaginal discharge or irritation (RR = 6.1), a previous abnormal Pap smear (RR = 3.8), or an early hysterectomy (RR = 6.7). In addition, there was some evidence that vaginal trauma might be involved, with nonsignificant and independent associations relating to regular douching with preparations other than water or vinegar (RR = 2.7) and frequent washing of the genital area (RR = 2.7). Further studies are needed to determine whether our findings persist among a larger series of cases.

Entities:  

Mesh:

Year:  1990        PMID: 2354827     DOI: 10.1016/0090-8258(90)90010-i

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  11 in total

1.  Vaginal douching and adverse health effects: a meta-analysis.

Authors:  J Zhang; A G Thomas; E Leybovich
Journal:  Am J Public Health       Date:  1997-07       Impact factor: 9.308

2.  Vaginal douching and reduced fertility.

Authors:  D D Baird; C R Weinberg; L F Voigt; J R Daling
Journal:  Am J Public Health       Date:  1996-06       Impact factor: 9.308

3.  Low-dose-rate definitive brachytherapy for high-grade vaginal intraepithelial neoplasia.

Authors:  Pierre Blanchard; Laurie Monnier; Isabelle Dumas; Philippe Morice; Patricia Pautier; Pierre Duvillard; Fares Azoury; Renaud Mazeron; Christine Haie-Meder
Journal:  Oncologist       Date:  2011-01-24

Review 4.  Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions.

Authors:  Anna R Giuliano; Guillermo Tortolero-Luna; Elena Ferrer; Ann N Burchell; Silvia de Sanjose; Susanne Kruger Kjaer; Nubia Muñoz; Mark Schiffman; F Xavier Bosch
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

5.  Vaginal cells of smokers are more resistant to human papillomavirus infection than that of non-smokers.

Authors:  Afsoon Moktar; Srivani Ravoori; Manicka V Vadhanam; Jianmin Pan; Shesh N Rai; Alfred B Jenson; Lynn P Parker; Ramesh C Gupta
Journal:  Exp Mol Pathol       Date:  2012-11-05       Impact factor: 3.362

6.  Post-hysterectomy vaginal cuff cancer secondary to HPV infection and CIN: A case report.

Authors:  Xiaoxia Liu; Ying Yue; Shan Zong
Journal:  Pak J Med Sci       Date:  2013-07       Impact factor: 1.088

7.  Risk of cancer in patients with genital warts: A nationwide, population-based cohort study in Taiwan.

Authors:  Ching-Yi Cho; Yu-Cheng Lo; Miao-Chiu Hung; Chou-Cheng Lai; Chun-Jen Chen; Keh-Gong Wu
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

8.  Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers.

Authors:  Eliane Duarte-Franco; Eduardo L Franco
Journal:  BMC Womens Health       Date:  2004-08-25       Impact factor: 2.809

9.  Protein expression patterns in primary carcinoma of the vagina.

Authors:  K Hellman; A A Alaiya; K Schedvins; W Steinberg; A-C Hellström; G Auer
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

10.  Detection of human papillomavirus-16 e6-oncoprotein in epithelial ovarian tumors samples of iraqi patients.

Authors:  Fahem Mohsin Mahmood; Haider Sabah Kadhim; Liqaa Riadh Mousa Al Khuzaee
Journal:  Jundishapur J Microbiol       Date:  2014-09-01       Impact factor: 0.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.